On Assignment, Inc.  

(Public, NYSE:ASGN)   Watch this stock  
Find more results for William R. Hanson´┐Ż
-2.09 (-5.97%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 32.86 - 34.85
52 week 30.60 - 51.00
Open 34.82
Vol / Avg. 475,008.00/351,558.00
Mkt cap 1.74B
P/E 23.34
Div/yield     -
EPS 1.41
Shares 52.80M
Beta 2.69
Inst. own 93%
Feb 17, 2016
Q4 2015 On Assignment Inc Earnings Call - 4:30PM EST - Add to calendar
Feb 17, 2016
Q4 2015 On Assignment Inc Earnings Release - 4:00PM EST - Add to calendar
Nov 12, 2015
On Assignment Inc at SunTrust Robinson Humphrey Financial Tech, Business & Government Services Conference
Nov 11, 2015
On Assignment Inc at Wells Fargo Technology, Media & Telecom Conference
Nov 10, 2015
On Assignment Inc at JPMorgan Ultimate Services Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 4.35% 4.25%
Operating margin 9.00% 7.86%
EBITD margin - 9.92%
Return on average assets 5.56% 6.25%
Return on average equity 13.46% 12.40%
Employees 2,700 -
CDP Score - -


26745 Malibu Hills Rd
CALABASAS, CA 91301-5355
United States - Map
+1-818-8787900 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.

Officers and directors

Jeremy M. Jones Independent Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter T. Dameris President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Edward L. Pierce Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Randolph C. Blazer President of Apex
Age: 60
Bio & Compensation  - Reuters
Michael J. McGowan Chief Operating Officer; President - Oxford Global Resources
Age: 61
Bio & Compensation  - Reuters
James L. Brill Senior Vice President, Chief Administrative Officer
Age: 63
Bio & Compensation  - Reuters
Theodore S. Hanson Chief Financial Officer, Apex Systems and President, Lab Support division
Age: 46
Bio & Compensation  - Reuters
William E. Brock Independent Director
Age: 84
Bio & Compensation  - Reuters
Brian T. Callaghan Independent Director
Age: 44
Bio & Compensation  - Reuters
Jonathan S. Holman Independent Director
Age: 70
Bio & Compensation  - Reuters